Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $103,000.00 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 4,000 shares of the firm’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $25.75, for a total value of $103,000.00. Following the transaction, the insider owned 6,897,764 shares of the company’s stock, valued at $177,617,423. The trade was a 0.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Stock Performance

Shares of OrthoPediatrics stock opened at $23.65 on Friday. The stock has a market cap of $617.50 million, a price-to-earnings ratio of -14.08 and a beta of 0.98. The firm’s 50-day moving average is $21.41 and its 200 day moving average is $18.66. OrthoPediatrics Corp. has a 1 year low of $14.42 and a 1 year high of $26.74. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.04. The business had revenue of $70.51 million during the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. Sell-side analysts anticipate that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have weighed in on KIDS shares. Needham & Company LLC boosted their target price on OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. Truist Financial set a $22.00 price objective on shares of OrthoPediatrics in a research report on Wednesday, August 5th. TD Cowen restated a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $26.44.

Institutional Trading of OrthoPediatrics

Large investors have recently added to or reduced their stakes in the business. AIGH Capital Management LLC purchased a new stake in OrthoPediatrics during the second quarter valued at approximately $5,161,000. Wasatch Advisors LP boosted its stake in shares of OrthoPediatrics by 56.6% during the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock worth $9,865,000 after acquiring an additional 186,357 shares during the last quarter. Roubaix Capital LLC boosted its stake in shares of OrthoPediatrics by 23.8% during the 1st quarter. Roubaix Capital LLC now owns 290,047 shares of the company’s stock worth $4,603,000 after acquiring an additional 55,724 shares during the last quarter. Granahan Investment Management LLC grew its position in shares of OrthoPediatrics by 35.1% during the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock valued at $14,231,000 after acquiring an additional 232,760 shares during the period. Finally, AWM Investment Company Inc. bought a new stake in shares of OrthoPediatrics during the 2nd quarter valued at $4,537,000. 69.05% of the stock is currently owned by institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.